Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab) Supplier, Suppliers, Supply, Supplies Infectious Disease Rapid Test ~ Setia Scientific Solution

Setia Scientific Solution
Suite 33-01, 33rd Floor, Menara Keck Seng,
203, Jalan Bukit Bintang,
55100 Kuala Lumpur,
Malaysia.

+6018-789 7171

+603-3191 3313

Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab)

The Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab) Combo Rapid Test

(Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of

Covid-19, Influenza A, Influenza B, Respiratory Syncytial Virus(RSV), Adenovirus and

M.pneumoniae antigens in nasopharyngeal swab specimens from individuals with suspected

Covid-19/Influenza/RSV/Adenovirus/M.pneumoniae infection in conjunction with clinical

presentation and the results of other laboratory tests.

Results are for the detection of Covid-19, Influenza A+B, RSV, Adenovirus and M.pneumoniae

antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of

infection. Positive results indicate the presence of correlative antigens, but clinical correlation with

patient history and other diagnostic information is necessary to determine infection status. Positive

results do not rule out other bacterial/viral infection. The agent detected may not be the definite cause

of disease.

Negative results do not preclude Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae infection

and should not be used as the sole basis for treatment or patient management decisions. Negative

results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient

management. Negative results should be considered in the context of a patient’s recent exposures,

history and the presence of clinical signs and symptoms consistent with COVID-19, Influenza A+B,

RSV, Adenovirus and M.pneumoniae.

The Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test is

intended for use by trained clinical laboratory personnel.

DIRECTIONS FOR USE

Allow the test, extracted specimen and/or controls to equilibrate to room temperature (15-30°C)

prior to testing.

1. Remove the test from the sealed foil pouch and use it within one hour. Best results will be obtained if

the test is performed immediately after opening the foil pouch.

2. Invert the specimen collection tube and add 3 drops of the extracted specimen to each of the

specimen well(S) respectively and then start the timer.

3. Wait for the colored line(s) to appear. Read the result at 15 minutes. Do not interpret the result after

20 minutes.

Cat. No.	Product Description	Specimen	Format	Kit Size	Cut-Off	Status
IRT-ACO555	Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab)	Nasopharyngeal Swab	Cassette	10 T	See Insert	CE

Please leave your enquiry here, we will reply as soon as possible.
Name*
Company Name
Product Interested
Quantity
Email*
Contact No.*
Messages*